Genetic study for birth defects with unknown causes
Part of Genetic & congenital clinical trials.
This study looks for rare genetic changes that might explain birth defects when standard tests have not found a cause. It could help families understand why a baby has a structural problem and may guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant with one baby, not twins or more.
- The baby has a structural abnormality seen on an ultrasound.
- Standard genetic tests (like WES, karyotyping, CMA) have not found a cause.
- If a suspicious gene variant was found, no second variant was identified.
- You must have had a prenatal diagnostic procedure (like amniocentesis) and be willing to have more tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study looks for genetic causes of birth defects in newborn babies. If your baby has a suspected genetic condition and other tests haven't found a clear cause, this study may help find answers.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
This study uses a new genetic technique to find hidden causes in people with multiple birth defects or intellectual disability who had standard genetic tests come back normal. It might help identify a genetic reason when other tests did not.
This study offers genetic sequencing to find the cause of certain serious fetal problems, such as structural anomalies, severe growth restriction, or unexplained pregnancy loss after 14 weeks. It aims to help families understand why the issue occurred and guide future care.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
Hear when a new Prenatal Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.